Why InflaRx Stock Skyrocketed This Week
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
What happened
InflaRx (NASDAQ: IFRX) stock soared this week on news that one of the company’s treatments for COVID-19 had received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). The company’s share price closed out the shortened trading week up 183
InflaRx (NASDAQ: IFRX) stock soared this week on news that one of the company’s treatments for COVID-19 had received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). The company’s share price closed out the shortened trading week up 183
:max_bytes(150000):strip_icc():format(jpeg)/savingsvscdnews-98809008e8464a429fd41d4c5a32dd38.jpg "What Metrics Can Be Used to Evaluate Companies in the Financial Services Sector?")
:max_bytes(150000):strip_icc():format(jpeg)/FPM-Best-Personal-Loans-Methodology-Recirc-468fcab5bfa84ae485bd56843cf5c0eb.png "How We Review and Rate Personal Loan Lenders")
